Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
RGS13
Introduction
Regulator of G-protein signaling 13 is a protein that in humans is encoded by the RGS13 gene.[1][2]
RGS 13 is a member of R4 subfamily of RGS (Regulators of G Protein Signaling) proteins which have only short peptide sequences flanking the RGS domain. RGS 13 suppresses the immunoglobulin E– mediated allergic responses.[3]
The protein encoded by this gene is a member of the regulator of G protein signaling (RGS) family. RGS family members share similarity with S. cerevisiae SST2 and C. elegans egl-10 proteins, which contain a characteristic conserved RGS domain. RGS proteins accelerate GTPase activity of G protein alpha-subunits, thereby driving G protein into their inactive GDP-bound form, thus negatively regulating G protein signaling. RGS proteins have been implicated in the fine tuning of a variety of cellular events in response to G protein-coupled receptor activation. The biological function of this gene, however, is unknown. Two transcript variants encoding the same isoform exist.[2]
References
References
- ↑ Johnson EN, Druey KM (May 2002). “Functional characterization of the G protein regulator RGS13”. J Biol Chem. 277 (19): 16768–16774. doi:10.1074/jbc.M200751200. PMID 11875076.
- ↑ 2.0 2.1 “Entrez Gene: RGS13 regulator of G-protein signalling 13”.
- ↑ Bansal G, Xie Z, Rao S, Nocka KH, Druey KM (2008). “Suppression of immunoglobulin E-mediated allergic responses by regulator of G protein signaling 13”. Nat. Immunol. 9 (1): 73–80. doi:10.1038/ni1533. PMC 2387203. PMID 18026105.
Further reading
Further reading
- Gregory SG, Barlow KF, McLay KE, et al. (2006). “The DNA sequence and biological annotation of human chromosome 1”. Nature. 441 (7091): 315–321. doi:10.1038/nature04727. PMID 16710414.
- Han JI, Huang NN, Kim DU, Kehrl JH (2006). “RGS1 and RGS13 mRNA silencing in a human B lymphoma line enhances responsiveness to chemoattractants and impairs desensitization”. J. Leukoc. Biol. 79 (6): 1357–1368. doi:10.1189/jlb.1105693. PMID 16565322.
- Gerhard DS, Wagner L, Feingold EA, et al. (2004). “The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)”. Genome Res. 14 (10B): 2121–2127. doi:10.1101/gr.2596504. PMC 528928. PMID 15489334.
- Islam TC, Asplund AC, Lindvall JM, et al. (2003). “High level of cannabinoid receptor 1, absence of regulator of G protein signalling 13 and differential expression of Cyclin D1 in mantle cell lymphoma”. Leukemia. 17 (9): 1880–1890. doi:10.1038/sj.leu.2403057. PMID 12970790.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). “Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences”. Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–16903. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932.
- Sierra DA, Gilbert DJ, Householder D, et al. (2002). “Evolution of the regulators of G-protein signaling multigene family in mouse and human”. Genomics. 79 (2): 177–185. doi:10.1006/geno.2002.6693. PMID 11829488.
- Druey KM, Blumer KJ, Kang VH, Kehrl JH (1996). “Inhibition of G-protein-mediated MAP kinase activation by a new mammalian gene family”. Nature. 379 (6567): 742–746. doi:10.1038/379742a0. PMID 8602223.